Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för teicoplanin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2015-02-12

Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections.

Nakamura A, Takasu O, Sakai Y, Sakamoto T, Yamashita N, Mori S, Morita T, Nabeta M, Hirayu N, Yoshiyama N, Moroki M, Tashiro K, Kannae M.

J Infect Chemother · journal article · DOI 10.1016/j.jiac.2015.02.002

Bibliografisk träff 2015-01-23

Aerosol Route to Administer Teicoplanin in Mechanical Ventilation: In Vitro Study, Lung Deposition and Pharmacokinetic Analyses in Pigs.

Guillon A, Mercier E, Lanotte P, Haguenoer E, Darrouzain F, Barc C, Sarradin P, Si-Tahar M, Heuzé-Vourc'h N, Diot P, Vecellio L.

J Aerosol Med Pulm Drug Deliv · journal article · DOI 10.1089/jamp.2014.1164

Bibliografisk träff 2014-10-30

Cytochrome P450 OxyBtei catalyzes the first phenolic coupling step in teicoplanin biosynthesis.

Haslinger K, Maximowitsch E, Brieke C, Koch A, Cryle MJ.

Chembiochem · research support, non-u.s. gov't; journal article · DOI 10.1002/cbic.201402441

Bibliografisk träff 2014-09-15

Population pharmacokinetics of teicoplanin in children.

Ramos-Martín V, Paulus S, Siner S, Scott E, Padmore K, Newland P, Drew RJ, Felton TW, Docobo-Pérez F, Pizer B, Pea F, Peak M, Turner MA, Beresford MW, Hope WW.

Antimicrob Agents Chemother · clinical trial; research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.03685-14

Bibliografisk träff 2014-09-03

Teicoplanin therapy for MRSA bacteraemia: a retrospective study emphasizing the importance of maintenance dosing in improving clinical outcomes.

Lee CH, Tsai CY, Li CC, Chien CC, Liu JW.

J Antimicrob Chemother · journal article · DOI 10.1093/jac/dku335

Bibliografisk träff 2014-08-20

Evaluation of teicoplanin concentrations and safety analysis in neonates.

Yamada T, Kubota T, Nakamura M, Ochiai M, Yonezawa M, Yano T, Kawashiri T, Egashira N, Hara T, Masuda S.

Int J Antimicrob Agents · journal article · DOI 10.1016/j.ijantimicag.2014.07.005

Bibliografisk träff 2014-03-21

Therapeutic drug concentrations of teicoplanin in clinical settings.

Nah SY, Im JH, Yeo JY, Baek JH, Kim CW, Nam MS, Lee HK, Chung MH, Lee JS.

Infect Chemother · research-article; journal article · DOI 10.3947/ic.2014.46.1.35

Bibliografisk träff 2014-02-10

Composition specification of teicoplanin based on its estimated relative bioavailability.

Boix-Montañes A, Garcia-Arieta A.

Drug Dev Ind Pharm · journal article · DOI 10.3109/03639045.2013.858733

Bibliografisk träff 1992-08-01

Teicoplanin metabolism in humans.

Bernareggi A, Borghi A, Borgonovi M, Cavenaghi L, Ferrari P, Vékey K, Zanol M, Zerilli LF.

Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.36.8.1744